Researchers at the University of Wollongong and IHMRI are seeking participants to take part in a study investigating a potential treatment which may help improve brain structure and function, psychological wellbeing and quality of life in people living with early-stage dementia.
Participants needed include:
- People aged 55 to 80 years recently diagnosed (in the last two years) with early-stage dementia;
- People who live at home, who have someone to support them throughout the duration of the study (e.g. family member, caregiver).
What does participation involve?
- We will screen interested individuals with a face-to-face interview to determine their suitability to participate, in consultation with their doctor.
- Eligible and willing participants will be required to take a capsule of either the trial drug or a placebo each morning and evening for 12 weeks.
- Participants and their supporting person will be asked to complete three separate testing sessions at the beginning (across two days, 4 hours), middle
(1 hour) and end (across two days, 4 hours) of the 12 weeks. - These sessions will include interviews about your health and wellbeing, taking body measurements, providing blood samples, answering questionnaires and having a total of two MRI scans.
- Participants and their supporting person will also be asked to take part in weekly home visits to monitor ongoing wellbeing.
For more information, please contact Dr Jessica Bartschi by phone on
02 4221 3732 or by email at jmills@uow.edu.au.
The study has been approved by ethics ref number: ETH2020/02708
